Author: Iryna
The government supported the creation in Ukraine of an office of the EU Research and Innovation Program “Horizon Europe”
On August 4, 2023, at a meeting of the Cabinet of Ministers of Ukraine, a draft act “Some Issues of…
Tape magnetic cores made of nanocrystalline alloys
Purpose. For reliable and energy-efficient transformers and chokes used in electronic, electrical and radio industries and as part of special…
Helicon ion source
Purpose. Use in plasma technology as an ion source for nano- and microanalytical analyzers, mass spectrometers with inductively coupled plasma….
The next round of applications to the Ukrainian-Australian Research Foundation is open
The Australian Academy of Sciences, in partnership with the Breakthrough Prize Foundation, is implementing the next round of support for…
Highly efficient source of multiply charged metal ions
Purpose. For carrying out ion implantation of materials with single/double row metal ions (Be, Fe, Cr, Ni, Zr, Mo, W,…
Startup Nights Switzerland (November 2-3, 2023)
Startup Nights is a technology conference that brings together innovators from all over the world. And, according to the Ministry…
The formation of consortia and the submission of applications for participation in the European Research Council Starting Grant 2024 (ERC Starting Grant 2024) continues
As part of the European Union’s Horizon Europe program, the formation of consortia and the submission of applications for participation…
Computer program “Tool system for automatic tuning of programs Tuninggenie”
Purpose. Automated dynamic performance optimization of the algorithm of sequential and parallel programs in a given computing environment based on…
UkrISTEI signed a Memorandum of Cooperation with the UNOIPI
SSO “Ukrainian Institute of Scientific and Technical Expertise and Information” and “Ukrainian National Office of Intellectual Property and Innovation” (UkrNOIVI)…
Technology for obtaining pm-149 for radiotherapy of oncological diseases
Purpose. The Pm-149 isotope can be used for palliative therapy of bone metastases, as well as a pharmaceutical for radiotherapy…